These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

166 related items for PubMed ID: 17261434

  • 1. Sirolimus therapy of focal segmental glomerulosclerosis is associated with nephrotoxicity.
    Cho ME, Hurley JK, Kopp JB.
    Am J Kidney Dis; 2007 Feb; 49(2):310-7. PubMed ID: 17261434
    [Abstract] [Full Text] [Related]

  • 2. A prospective, open-label trial of sirolimus in the treatment of focal segmental glomerulosclerosis.
    Tumlin JA, Miller D, Near M, Selvaraj S, Hennigar R, Guasch A.
    Clin J Am Soc Nephrol; 2006 Jan; 1(1):109-16. PubMed ID: 17699197
    [Abstract] [Full Text] [Related]

  • 3. Tacrolimus therapy in adults with steroid- and cyclophosphamide-resistant nephrotic syndrome and normal or mildly reduced GFR.
    Li X, Li H, Ye H, Li Q, He X, Zhang X, Chen Y, Han F, He Q, Wang H, Chen J.
    Am J Kidney Dis; 2009 Jul; 54(1):51-8. PubMed ID: 19406543
    [Abstract] [Full Text] [Related]

  • 4. Treatment of focal and segmental glomerulosclerosis in adults with tacrolimus monotherapy.
    Duncan N, Dhaygude A, Owen J, Cairns TD, Griffith M, McLean AG, Palmer A, Taube D.
    Nephrol Dial Transplant; 2004 Dec; 19(12):3062-7. PubMed ID: 15507477
    [Abstract] [Full Text] [Related]

  • 5. Clinical course of primary focal segmental glomerulosclerosis (FSGS) in Turkish children: a report from the Turkish Pediatric Nephrology FSGS Study Group.
    Beşbaş N, Ozaltin F, Emre S, Anarat A, Alpay H, Bakkaloğlu A, Baskin E, Buyan N, Dönmez O, Düşünsel R, Ekim M, Göko F, Gür-Güven A, Kavukçu S, Mir S, Sönmez F.
    Turk J Pediatr; 2010 Dec; 52(3):255-61. PubMed ID: 20718182
    [Abstract] [Full Text] [Related]

  • 6. Long-term treatment of focal segmental glomerulosclerosis in children with cyclosporine given as a single daily dose.
    Chishti AS, Sorof JM, Brewer ED, Kale AS.
    Am J Kidney Dis; 2001 Oct; 38(4):754-60. PubMed ID: 11576878
    [Abstract] [Full Text] [Related]

  • 7. An Outcomes-Based Definition of Proteinuria Remission in Focal Segmental Glomerulosclerosis.
    Troost JP, Trachtman H, Nachman PH, Kretzler M, Spino C, Komers R, Tuller S, Perumal K, Massengill SF, Kamil ES, Oh G, Selewski DT, Gipson P, Gipson DS.
    Clin J Am Soc Nephrol; 2018 Mar 07; 13(3):414-421. PubMed ID: 29167190
    [Abstract] [Full Text] [Related]

  • 8. Duration of optimal therapy for idiopathic focal segmental glomerulosclerosis.
    Pokhariyal S, Gulati S, Prasad N, Sharma RK, Singh U, Gupta RK, Mittal S, Mehta B.
    J Nephrol; 2003 Mar 07; 16(5):691-6. PubMed ID: 14733415
    [Abstract] [Full Text] [Related]

  • 9. Pregnancy, Proteinuria, Plant-Based Supplemented Diets and Focal Segmental Glomerulosclerosis: A Report on Three Cases and Critical Appraisal of the Literature.
    Attini R, Leone F, Montersino B, Fassio F, Minelli F, Colla L, Rossetti M, Rollino C, Alemanno MG, Barreca A, Todros T, Piccoli GB.
    Nutrients; 2017 Jul 19; 9(7):. PubMed ID: 28753930
    [Abstract] [Full Text] [Related]

  • 10. Primary FSGS in Nephrotic Adults: Clinical Profile, Response to Immunosuppression and Outcome.
    Bagchi S, Agarwal S, Kalaivani M, Bhowmik D, Singh G, Mahajan S, Dinda A.
    Nephron; 2016 Jul 19; 132(2):81-5. PubMed ID: 26799973
    [Abstract] [Full Text] [Related]

  • 11. Combined therapy of tacrolimus and corticosteroids in cyclosporin-resistant or -dependent idiopathic focal glomerulosclerosis: a preliminary uncontrolled study with prospective follow-up.
    Segarra A, Vila J, Pou L, Majó J, Arbós A, Quiles T, Piera LL.
    Nephrol Dial Transplant; 2002 Apr 19; 17(4):655-62. PubMed ID: 11917061
    [Abstract] [Full Text] [Related]

  • 12. Pirfenidone slows renal function decline in patients with focal segmental glomerulosclerosis.
    Cho ME, Smith DC, Branton MH, Penzak SR, Kopp JB.
    Clin J Am Soc Nephrol; 2007 Sep 19; 2(5):906-13. PubMed ID: 17702727
    [Abstract] [Full Text] [Related]

  • 13. Unusual post-transplantation recurrence of focal segmental glomerulosclerosis which resolved with cyclosporine but not with sirolimus.
    Skhiri H, Morelon E, Noel LH, Mamzer-Bruneel MF, Legendre C, Peraldi MN, Kreis H.
    Transpl Int; 2005 Apr 19; 18(4):458-60. PubMed ID: 15773967
    [Abstract] [Full Text] [Related]

  • 14. Conversion of cyclosporine to sirolimus before 12 months is associated with marked improvement in renal function and low proteinuria in a South African renal transplant population.
    Maharaj S, Assounga AG.
    Exp Clin Transplant; 2010 Mar 19; 8(1):14-8. PubMed ID: 20199366
    [Abstract] [Full Text] [Related]

  • 15. Cyclosporine-based immunosuppressive therapy for patients with steroid-resistant focal segmental glomerulosclerosis: a meta-analysis.
    Chiou YY, Lee YC, Chen MJ.
    Curr Med Res Opin; 2017 Aug 19; 33(8):1389-1399. PubMed ID: 28436233
    [Abstract] [Full Text] [Related]

  • 16. Proteinuria Reduction and Kidney Survival in Focal Segmental Glomerulosclerosis.
    Troost JP, Trachtman H, Spino C, Kaskel FJ, Friedman A, Moxey-Mims MM, Fine RN, Gassman JJ, Kopp JB, Walsh L, Wang R, Gipson DS.
    Am J Kidney Dis; 2021 Feb 19; 77(2):216-225. PubMed ID: 32791086
    [Abstract] [Full Text] [Related]

  • 17. Treatment of resistant glomerular diseases with adrenocorticotropic hormone gel: a prospective trial.
    Bomback AS, Canetta PA, Beck LH, Ayalon R, Radhakrishnan J, Appel GB.
    Am J Nephrol; 2012 Feb 19; 36(1):58-67. PubMed ID: 22722778
    [Abstract] [Full Text] [Related]

  • 18. Evolution of glomerular filtration rate, renal injury markers, anemia, and angiotensin blockers use after change from calcineurin inhibitors to sirolimus in transplant patients with neoplasia versus chronic allograft nephropathy.
    Luna E, Cerezo I, Macias R, Villa J, Martinez C, Cubero J, Martinez R, Ferreira F, García C.
    Transplant Proc; 2011 Feb 19; 43(6):2187-90. PubMed ID: 21839229
    [Abstract] [Full Text] [Related]

  • 19. Focal segmental glomerulosclerosis is not a sufficient predictor of renal outcome in patients with membranous nephropathy.
    Heeringa SF, Branten AJ, Deegens JK, Steenbergen E, Wetzels JF.
    Nephrol Dial Transplant; 2007 Aug 19; 22(8):2201-7. PubMed ID: 17442739
    [Abstract] [Full Text] [Related]

  • 20. Recurrence of nephrotic proteinuria in children with focal segmental glomerulosclerosis after renal transplantation treated with plasmapheresis and immunoadsorption: case reports.
    Fencl F, Simková E, Vondrák K, Janda J, Chadimová M, Stejskal J, Seeman T.
    Transplant Proc; 2007 Dec 19; 39(10):3488-90. PubMed ID: 18089416
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.